Mika Derynck
Direttore/Membro del Consiglio presso ENLIVEN THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Mika Derynck
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/02/2023 | - |
| Independent Dir/Board Member | 23/02/2023 | - | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 19/01/2022 | - |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Mika Derynck
Formazione di Mika Derynck
| Boston University | Undergraduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
- Borsa valori
- Insiders
- Mika Derynck
- Esperienza
